跳到主要內容

Seim Robin Gene 的 Form 4 申報

Omnicell, Inc.OMCL,2021/8/10 申報

申報編號
0001179110-21-008091
申報時間
2021/8/10
交易日
2021/8/9
申報延遲
1 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 4 筆非衍生性交易。公開市場賣出合計 $101.4 萬。交易後 1 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Seim Robin GeneCIK 0001351911董事、董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2021/8/9Common StockS賣出處分−1,947$150.27F1−$292,575.6934,788直接
2021/8/9Common StockS賣出處分−2,291$151.43F2−$346,926.1332,497直接
2021/8/9Common StockS賣出處分−1,668$152.55F3−$254,453.430,829直接
2021/8/9Common StockS賣出處分−780$153.40F4−$119,65230,049直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.00 to $150.985. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

表 I 有 1 筆交易的價格引用這則附註。

F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.045 to $152.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

表 I 有 1 筆交易的價格引用這則附註。

F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.21 to $153.165. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

表 I 有 1 筆交易的價格引用這則附註。

F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $153.225 to $153.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)